| abstract |
The present invention relates to pharmaceutical combinations for the treatment of diseases associated with cell proliferation, migration or apoptosis of myeloma cells, or angiogenesis. The present invention also provides a method for treating the above-mentioned diseases, including co-administration of an effective amount of a specific active compound and / or adjunct treatment with radiation therapy, in a ratio that provides a cumulative and synergistic effect, and corresponding pharmaceutical combination preparations Relates to the combined use of these specific compounds and / or radiation therapeutics for the manufacture of |